PIRAMAL CRITICAL CARE, INC.
BETHLEHEM, PA

Piramal Critical Care (PCC), a business unit of Piramal Pharma, is the third largest producer of inhaled anesthetics and a global player in hospital generics. ‘Save lives with critical care solutions’ is much more than a purpose statement to us. We are motivated by our vision of commitment to delivering critical care solutions for patients and healthcare providers across the globe, while achieving sustainable and profitable growth for all the stakeholders. Piramal Critical Care maintains a wide presence across the US, Europe, and more than 100 countries across the globe. Our product portfolio includes inhalation anesthetics, injectable pain and anesthesia drugs, Intrathecal Baclofen therapy for spasticity management, and plasma volume expanders. Our products include Sevoflurane, Isoflurane, Halothane, Gablofen, Polygeline, Alfentanil, Fentanyl, Sufentanil and Etomidate. Piramal Critical Care marked its entry in the field of inhalation anesthetics in 2002 with the acquisition of ICI India Ltd. and was further built through strategic acquisitions. We recently acquired brands and all related Intellectual Property, including know-how to make both API and finished dosage forms, of a line of Janssen products. We also acquired a portfolio of intrathecal spasticity and pain management drugs from Mallinckrodt LLC. Ability to build successful partnerships has always been an integral part of our growth story. Looking ahead, we will increase the share of our existing products and add hospital pharmaceutical products to our portfolio.Piramal Critical Care has strong manufacturing and process development experience with wholly owned, state-of-the-art manufacturing facilities in the United States and India, inspected periodically by US FDA and the UK MHRA and other regulators. The strategic locations of our facilities help us supply high quality products around the world, timely at optimal costs. For our inhalation anesthesia products, we proudly use glass bottles manufactured by Piramal Glass, which is a global leader in delivering top, world-class glass packaging solutions for pharmaceuticals, cosmetics and perfumery business. Piramal Glass is the largest specialty glass player in Asia and has been the fastest growing glass company in the world for the last 10 years. Piramal Critical Care is committed to corporate social responsibility alongside Piramal Group. We collaborate with various partner organizations and proudly take an active role in providing hope and resources to those in need, as well as caring for our environment. The Piramal Group is a diversified conglomerate with offices in more than 30 countries and brand presence across 100 markets. Since the 1980s, we have evolved from a textile-centric business to one of India’s leading business conglomerates operating across sectors such as healthcare, life sciences, healthcare information management, financial services, specialty glass packaging, and real estate. Valued at US$10 Bn, the Group’s flagship company, Piramal Enterprises Limited, generates more than 51% of its revenues from international markets. The Piramal Foundation is our philanthropic arm that runs projects across healthcare, education, livelihood creation, and youth empowerment. Projects like Piramal Sarvajal and e-Swasthya are now Harvard Business School case studies. Acquisition of pharmaceuticals business of ICI India Limited Acquisition of Inhalation Anesthetic business of Rhodia Organique Ltd., UK Acquisition of business unit AltaSelect S.r.l. Acquisition of Injectable Anesthesia business of BSV, India Acquisition of Injectable Anesthesia and Pain Management products from Janssen, Belgium The core values of Piramal Group and Piramal Critical Care are an integral piece of our guiding philosophy. Values are what connect and divide us as human beings. They determine how we engage with others, what we value, what we love, and what we deem worth fighting for. Therefore, living by our values is not just important but imperative. – We are empowered to act decisively and create value. – We are consistent in our thought, speech, and action. Mike Teague is the Vice President of Supply Chain at Piramal Critical Care. He is responsible for overseeing production planning & inventory control, order fulfillment, procurement, sourcing and vendor management, logistics, distribution and warehouse management, and vaporizer operations, including the management of the key vaporizer vendor relationships. Mike began his career with Pfizer Inc. in the Groton Manufacturing Plant. Over the next 20 years, he was promoted through a series of positions overseeing pharmaceutical and chemical manufacturing and operations. After Pfizer, Mike consulted for many notable Fortune 500 firms such as Novartis, Pfizer, Fujisawa Pharmaceutical, Danisco, and Pepsi. During his time as a business development and pharmaceutical consultant, he traveled extensively where he was involved in due-diligence for acquisitions, joint-venture negotiations, competitive intelligence assessments, and technical transfers to Asia. In 2008, he headed a Bethlehem, Pennsylvania anesthetic manufacturing site, which was plagued with high costs, compliance and safety issues and an inability to meet demand prior to the Piramal acquisition in 2009, and turned it around. Today the site stands as a flagship site in the Piramal portfolio of operations. In 2012, Mike was promoted to Vice President of Supply Chain and charged with establishing and leading an integrated global supply chain for Piramal Critical Care. Piramal Critical Care’s core strength lies in its highly qualified global workforce of more than 400 employees across 16 countries Our emphasis lies in nurturing a sense of entrepreneurship and ownership that empowers you to excel while leaving your unique imprint on your craft. Our core values keep us grounded even while riding the waves of success, helping you focus on the task at hand. Our Purpose of ‘Doing Well and Doing Good’ is deeply embedded in our DNA – it’s not just our success that defines us, but the drive to ensure that our business and our people create a positive impact on society.